Stereotaxis Launches Hungary’s First Robotic Cardiology Program
ST. LOUIS, Missouri, USA | July 20, 2026 Stereotaxis announced the launch of Hungary’s first advanced robotic cardiology program...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
ST. LOUIS, Missouri, USA | July 20, 2026 Stereotaxis announced the launch of Hungary’s first advanced robotic cardiology program...
Riyadh, Saudi Arabia | July 21, 2026 King Faisal Specialist Hospital and Research Centre (KFSH) has achieved a global...
TAMPA, Fla., July 16, 2026 PainTEQ has unveiled new scientific evidence supporting its cortical-piercing posterior sacroiliac (SI) joint fixation...
TORONTO, July 16, 2026 SpinaFX Medical Inc. has achieved a significant regulatory milestone with the Medical Device Regulation (MDR)...
CAESAREA, Israel, July 6, 2026 IceCure Medical Ltd. has announced accelerating commercial adoption of its ProSenseâ„¢ cryoablation system in...
BOSTON, Massachusetts, USA – June 9, 2026 Novanta Inc. has announced a definitive agreement to acquire Riverpoint Medical in...
Hong Kong, China, May 25, 2026 Cornerstone Robotics (CSR) has announced that its Sentire® Endoscopic Surgical System has officially...
Hong Kong, China – May 25, 2026 Cornerstone Robotics (CSR) announced that its Sentire® Endoscopic Surgical System has officially...
BOSTON and YOKNEAM, Israel, May 14, 2026 Butterfly Medical announced the successful completion of an upsized $21 million Series...
SANTA CLARA, Calif., United States – May 5, 2026 Johnson & Johnson has announced pivotal clinical study results for...
